10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001638833-23-000097`
Period End Date	20230930
Filing Date	20231107
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	sgry-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 109 Cash Flow Statement 70 Stockholders Equity 50 Comprehensive Income 24

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$374.30M	USD	Point-in-time
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$425.50M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$236.00M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$282.90M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$462.80M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$456.30M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$69.40M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$71.40M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$34.70M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$31.40M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$73.30M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$79.00M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	125.96M	shares	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	126.49M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$876.20M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$921.00M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $425.5 and $374.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$939.70M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $425.5 and $374.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$876.60M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	126.49M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$4.18B	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$4.30B	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$190.30M	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$196.30M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$244.50M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$279.10M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$91.50M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$105.00M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$144.20M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$117.40M	USD	Point-in-time
Total assets	`Assets`	$6.68B	USD	Point-in-time
Total assets	`Assets`	$6.78B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$148.80M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$151.60M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$82.30M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$68.90M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$208.20M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$210.10M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$62.80M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$62.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$501.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$493.40M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.64B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.56B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$240.90M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$271.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$75.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$78.90M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$332.20M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$330.20M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$338.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$342.00M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 126,488,626 and 125,960,834, respectively	`CommonStockValueOutstanding`	$1.30M	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 126,488,626 and 125,960,834, respectively	`CommonStockValueOutstanding`	$1.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.49B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.48B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$77.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$76.20M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-568.20M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-557.30M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$2.00B	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$2.00B	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$981.90M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$942.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.11B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.98B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.78B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.68B	USD	Point-in-time

Income Statement 109 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$674.10M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$620.60M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.83B	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.01B	USD	3 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$195.00M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$546.30M	USD	3 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$185.50M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$592.40M	USD	3 Qtrs
Supplies	`SuppliesExpense`	$173.20M	USD	1 Quarter
Supplies	`SuppliesExpense`	$179.20M	USD	1 Quarter
Supplies	`SuppliesExpense`	$518.30M	USD	3 Qtrs
Supplies	`SuppliesExpense`	$549.80M	USD	3 Qtrs
Professional and medical fees	`ProfessionalFees`	$198.40M	USD	3 Qtrs
Professional and medical fees	`ProfessionalFees`	$219.90M	USD	3 Qtrs
Professional and medical fees	`ProfessionalFees`	$68.10M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$72.40M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.10M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$64.30M	USD	3 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$61.80M	USD	3 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.60M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$127.60M	USD	3 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$41.00M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$40.60M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$116.80M	USD	3 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$1.55B	USD	3 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$1.44B	USD	3 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$489.40M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$508.30M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$17.90M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$36.80M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$100.00M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$73.50M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$87.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$28.90M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$85.20M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$29.80M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$12.80M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$27.80M	USD	3 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$12.50M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$37.30M	USD	3 Qtrs
Grant funds	`GrantRevenue`	$1.10M	USD	3 Qtrs
Grant funds	`GrantRevenue`	-	USD	1 Quarter
Grant funds	`GrantRevenue`	$1.80M	USD	3 Qtrs
Grant funds	`GrantRevenue`	$500.00K	USD	1 Quarter
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-7.50M	USD	3 Qtrs
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-5.80M	USD	1 Quarter
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-3.20M	USD	3 Qtrs
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.20M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$9.40M	USD	3 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$2.40M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$8.10M	USD	3 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$3.50M	USD	1 Quarter
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	3 Qtrs
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$-8.10M	USD	3 Qtrs
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$-3.60M	USD	1 Quarter
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	Point-in-time
Litigation settlements	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-2.10M	USD	3 Qtrs
Other income, net	`OtherNonrecurringIncomeExpense`	$-2.40M	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-1.20M	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-7.40M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$591.50M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.78B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$546.50M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.58B	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$82.60M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$74.10M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$251.00M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$226.60M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-60.70M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-144.30M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-173.90M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-49.80M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$13.40M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$77.10M	USD	3 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$82.30M	USD	3 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$32.80M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$-6.30M	USD	3 Qtrs
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$7.80M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$13.40M	USD	3 Qtrs
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$3.10M	USD	1 Quarter
Net income	`ProfitLoss`	$88.60M	USD	3 Qtrs
Net income	`ProfitLoss`	$63.70M	USD	3 Qtrs
Net income	`ProfitLoss`	$29.70M	USD	1 Quarter
Net income	`ProfitLoss`	$5.60M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$34.60M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$30.60M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$94.90M	USD	3 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$99.50M	USD	3 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-4.90M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-10.90M	USD	3 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-31.20M	USD	3 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-25.00M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.35	USD	3 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.04	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.28	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.09	USD	3 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.28	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.04	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.09	USD	3 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.35	USD	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	125.56M	shares	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	88.91M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	88.60M	shares	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	125.75M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	125.75M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	125.56M	shares	3 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.60M	shares	3 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.91M	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$88.60M	USD	3 Qtrs
Net income	`ProfitLoss`	$63.70M	USD	3 Qtrs
Net income	`ProfitLoss`	$29.70M	USD	1 Quarter
Net income	`ProfitLoss`	$5.60M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$87.00M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$28.90M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$85.20M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$29.80M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseExpense`	$26.80M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$26.40M	USD	3 Qtrs
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-19.80M	USD	3 Qtrs
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-19.00M	USD	3 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.40M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$13.00M	USD	3 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$5.00M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$13.20M	USD	3 Qtrs
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-7.50M	USD	3 Qtrs
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-5.80M	USD	1 Quarter
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-3.20M	USD	3 Qtrs
Net loss on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.20M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$12.40M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-10.80M	USD	3 Qtrs
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$500.00K	USD	3 Qtrs
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$2.70M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.40M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$18.20M	USD	3 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-53.70M	USD	3 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-1.20M	USD	3 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$20.90M	USD	3 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-21.60M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$151.60M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$231.20M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$57.90M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$69.00M	USD	3 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$82.60M	USD	3 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$48.80M	USD	3 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	-	USD	3 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$25.80M	USD	3 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$50.20M	USD	3 Qtrs
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$95.10M	USD	3 Qtrs
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$11.50M	USD	3 Qtrs
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$1.00M	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$26.30M	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$11.60M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-167.50M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-235.70M	USD	3 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$81.50M	USD	3 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$107.10M	USD	3 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$119.40M	USD	3 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$51.20M	USD	3 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$1.50M	USD	3 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$111.00M	USD	3 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$110.50M	USD	3 Qtrs
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$700.00K	USD	3 Qtrs
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$-3.90M	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-6.30M	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-11.10M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-151.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-110.60M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-46.90M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-235.10M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$282.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$236.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$154.80M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$282.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$236.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$154.80M	USD	Point-in-time

Stockholders Equity 50 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (shares)	`CommonStockSharesOutstanding`	126.49M	shares	Point-in-time
Balance at beginning of period (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.98B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$23.10M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-2.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-6.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$4.30M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$32.20M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$46.60M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.70M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.50M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$7.70M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.50M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$5.00M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.40M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$19.00M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-11.30M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$38.50M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$56.80M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$13.90M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.80M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$49.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$46.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$-29.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$27.90M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$1.70M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$-900.00K	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$24.60M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$23.80M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$23.80M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$30.20M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$25.00M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$27.70M	USD	1 Quarter
Balance at end of period (shares)	`CommonStockSharesOutstanding`	126.49M	shares	Point-in-time
Balance at end of period (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.04B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.98B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	3 Qtrs
Net income	`ProfitLoss`	$88.60M	USD	3 Qtrs
Net income	`ProfitLoss`	$63.70M	USD	3 Qtrs
Net income	`ProfitLoss`	$29.70M	USD	1 Quarter
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	1 Quarter
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	1 Quarter
Net income	`ProfitLoss`	$5.60M	USD	1 Quarter
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	3 Qtrs
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$38.50M	USD	1 Quarter
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$114.30M	USD	3 Qtrs
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$800.00K	USD	3 Qtrs
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-1.80M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$27.90M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$178.00M	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$44.10M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$89.40M	USD	3 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$94.90M	USD	3 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$30.60M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$99.50M	USD	3 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$34.60M	USD	1 Quarter
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-6.70M	USD	1 Quarter
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$13.50M	USD	1 Quarter
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$83.10M	USD	3 Qtrs
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-10.10M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.